Effient (Eli Lilly and Company)
Welcome to the PulseAid listing for the Effient drug offered from Eli Lilly and Company. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
NON-PROPRIETARY NAME: | Prasugrel hydrochloride |
SUBSTANCE NAME: | PRASUGREL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-10 |
END MARKETING DATE: | 0000-00-00 |
Effient HUMAN PRESCRIPTION DRUG Details:
Item Description | Effient from Eli Lilly and Company |
LABELER NAME: | Eli Lilly and Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2009-07-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0002-5121_dec2c4de-adab-42c6-a981-015a1a9be91b |
PRODUCT NDC: | 0002-5121 |
APPLICATION NUMBER: | NDA022307 |
Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: